趋近偏向修正作为戒烟治疗的附加干预:一项随机对照试验
这项随机、对照、双盲、单中心优效性试验纳入351名参与者,在1天认知行为戒烟治疗(TAU)后随机分为TAU+趋近偏向修正(ApBM)、TAU+假训练或仅TAU三组,训练持续7天。主要结局为6个月随访时的长期戒断率,意向性分析显示三组分别为19.3%、17.4%和16.2%,组间无显著差异。结论认为ApBM作为戒烟附加治疗并不优于假训练或仅TAU。
要点
- ApBM作为戒烟附加治疗未显著提高6个月长期戒断率。
- 三组戒断率分别为19.3%、17.4%和16.2%,组间无显著差异。
- ApBM在酒精使用障碍中的阳性效应未外推至烟草使用障碍。
核心结论
- TAU+ApBM在6个月长期戒断率上不显著优于TAU+假训练或仅TAU。
研究设计与样本
- 随机、对照、双盲、单中心优效性试验,共351名参与者。
- 参与者先接受1天认知行为戒烟治疗(TAU),随后随机分入TAU+ApBM组(N=119)、TAU+假训练组(N=115)或仅TAU组(N=117)。
- 训练 sessions 持续7天,主要结局为6个月随访时的长期戒断。
主要发现
- 意向性分析中,6个月戒断率:TAU+ApBM组19.3%(95% CI=12.13, 26.53),TAU+假训练组17.4%(95% CI=10.36, 24.42),仅TAU组16.2%(95% CI=9.46, 23.02)。
- 三组戒断率之间无显著差异。
关键数值与推荐
- 戒断分类标准:非吸烟者为连续戒断6个月、自戒烟尝试以来吸烟≤5支且呼气CO水平≤9 ppm;复吸者为无客观吸烟状态验证、呼气CO水平≥10 ppm或自戒烟尝试以来吸烟>5支。
临床怎么用
- 本研究结果不支持将ApBM作为戒烟治疗的附加干预常规使用。
- 临床决策时应注意到ApBM在烟草使用障碍中的疗效未获证实。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Smoking is associated with an approach bias toward smoking-related stimuli. Approach bias modification (ApBM), a computerized training specifically designed to modify this approach bias, has shown positive effects in patients with alcohol use disorder; however, its efficacy as an add-on in smoking cessation treatment is inconclusive. The aim of this clinical trial was to investigate whether ApBM as an add-on to smoking cessation treatment results in higher 6-month prolonged abstinence rates compared to two control conditions. METHODS: In this randomized, controlled, double-blind, single-center superiority trial, 351 participants received a 1-day cognitive-behavioral smoking cessation treatment (treatment as usual [TAU]) and were subsequently randomized to either TAU+ApBM (N=119), TAU+sham training (N=115), or TAU only (N=117). Training sessions were conducted over 7 days. The primary outcome was prolonged abstinence at 6-month follow-up. Participants were classified as either nonsmoking (continuous abstinence for 6 months, ≤5 cigarettes since quit attempt, and breath CO level ≤9 ppm) or relapsed (no objective verification of smoking status, breath CO level ≥10 ppm, >5 cigarettes since quit attempt). RESULTS: In the intention-to-treat analyses, abstinence rates at 6 months were 19.3% (95% CI=12.13, 26.53) for TAU+ApBM, 17.4% (95% CI=10.36, 24.42) for TAU+sham training, and 16.2% (95% CI=9.46, 23.02) for TAU only, with no significant differences between groups. CONCLUSIONS: This large-scale clinical trial demonstrates that TAU+ApBM is not significantly superior to TAU+sham training or TAU only. ApBM has been included in Australian and German alcohol use disorder treatment guidelines, but this randomized controlled trial shows that positive effects do not apply to tobacco use disorder.
引用
- Wittekind CE, Takano K, Motka F, et al. Approach Bias Modification as an Add-On to Smoking Cessation Treatment: A Randomized Controlled Trial. Am J Psychiatry. 2026. PMID: 41634907. doi:10.1176/appi.ajp.20250189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。